Psoriasis - Treatment with a synthetic antimalarial drug Factor
Last reviewed for CCPS 10 June 2012.
Investigative Documents
Claimant Report - Treatment with a synthetic antimalarial drug - Psoriasis [CR9238]
Medical Report - Treatment with a synthetic antimalarial drug - Psoriasis [MR9311]
Preliminary questions [34234]
there is some evidence that treatment with a synthetic antimalarial drug may be a factor in the development or worsening of the condition under consideration.34236 the veteran has been treated with a synthetic antimalarial drug at some time.
34237 — the veteran has established the causal connection between the treatment with a synthetic antimalarial drug and VEA service for psoriasis.
34238 — the veteran has established the causal connection between the treatment with a synthetic antimalarial drug and VEA service for the clinical onset of psoriasis.
34242 — the veteran has established the causal connection between the treatment with a synthetic antimalarial drug and operational service for the clinical onset of psoriasis.
or
34243 — the veteran has established the causal connection between the treatment with a synthetic antimalarial drug and eligible service for the clinical onset of psoriasis.
or
the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service. the condition under consideration permanently worsened.34239 — the veteran has established the causal connection between the treatment with a synthetic antimalarial drug and VEA service for the clinical worsening of psoriasis.
34244 — the veteran has established the causal connection between the treatment with a synthetic antimalarial drug and operational service for the clinical worsening of psoriasis.
or
34245 — the veteran has established the causal connection between the treatment with a synthetic antimalarial drug and eligible service for the clinical worsening of psoriasis.
Clinical onset and operational service [34242]
as a consequence of operational service, the veteran was treated with a synthetic antimalarial drug. as a consequence of operational service, the veteran was treated with a synthetic antimalarial drug at the time of the clinical onset of the condition under consideration.or
the veteran was treated with a synthetic antimalarial drug for treatment of an illness or injury which is identifiable.34255 for treatment of the identified illness or injury, the veteran was treated with a synthetic antimalarial drug at the time of the clinical onset of the condition under consideration.
34257 — the identified illness or injury for which the veteran was treated with a synthetic antimalarial drug is causally related to operational service.
Clinical onset and eligible service [34243]
as a consequence of eligible service, the veteran was treated with a synthetic antimalarial drug. as a consequence of eligible service, the veteran was treated with a synthetic antimalarial drug at the time of the clinical onset of the condition under consideration.or
the veteran was treated with a synthetic antimalarial drug for treatment of an illness or injury which is identifiable.34255 for treatment of the identified illness or injury, the veteran was treated with a synthetic antimalarial drug at the time of the clinical onset of the condition under consideration.
34258 — the identified illness or injury for which the veteran was treated with a synthetic antimalarial drug is causally related to eligible service.
Clinical worsening and operational service [34244]
as a consequence of operational service, the veteran was treated with a synthetic antimalarial drug. as a consequence of operational service, the veteran was treated with a synthetic antimalarial drug at the time of the clinical worsening of the condition under consideration.or
the veteran was treated with a synthetic antimalarial drug for treatment of an illness or injury which is identifiable.34256 for treatment of the identified illness or injury, the veteran was treated with a synthetic antimalarial drug at the time of the clinical worsening of the condition under consideration.
34257 — the identified illness or injury for which the veteran was treated with a synthetic antimalarial drug is causally related to operational service.
the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury, for which the veteran was treated with a synthetic antimalarial drug, is causally related.Clinical worsening and eligible service [34245]
as a consequence of eligible service, the veteran was treated with a synthetic antimalarial drug. as a consequence of eligible service, the veteran was treated with a synthetic antimalarial drug at the time of the clinical worsening of the condition under consideration.or
the veteran was treated with a synthetic antimalarial drug for treatment of an illness or injury which is identifiable.34256 for treatment of the identified illness or injury, the veteran was treated with a synthetic antimalarial drug at the time of the clinical worsening of the condition under consideration.
34258 — the identified illness or injury for which the veteran was treated with a synthetic antimalarial drug is causally related to eligible service.
the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury, for which the veteran was treated with a synthetic antimalarial drug, is causally related.